share_log

B of A Securities Maintains Neutral on Axsome Therapeutics, Lowers Price Target to $95

B of A Securities Maintains Neutral on Axsome Therapeutics, Lowers Price Target to $95

美国银行证券对axsome therapeutics保持中立,将目标股价下调至95美元
Benzinga ·  07/18 12:50

B of A Securities analyst Jason Gerberry maintains Axsome Therapeutics (NASDAQ:AXSM) with a Neutral and lowers the price target from $97 to $95.

BofA证券分析师Jason Gerberry维持Axsome Therapeutics(纳斯达克:axsome therapeutics)的中立评级,并将价格目标从97美元下调至95美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发